Treatment Horizons

Treatment Horizons by Chael Needle Surpassing Expectations ViiV Healthcare introduces its first FDA-approved agent ViiV Healthcare is exclusively devoted to the treatment of HIV disease, and the...

Two Anti-Cancer Drugs Are Tapped in the Fight Against HIV by Chael Needle New types of drugs are needed in the fight against HIV but some of...

Pipeline Report Treatment Action Group provides updates on treatments for HIV, HCV & TB by Hank Trout Treatment Action Group (TAG) has announced the release of the...

In February 2018, ViiV Healthcare announced the start of a forty-eight-week phase III study designed to determine whether adults with HIV-1 who have achieved...

When it comes to Effective HIV reform, don’t throw the baby out with the bathwater by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD LifeGuide Extensive progress in...

Without the Pill Box? The First Long-Acting Injectable Regimen for Individuals Living with HIV Comes of Age by Mel Baker A funny thing happened on the way to...

Treatment Horizons by Chael Needle A nonprofit creates a new support system for the uninsured Joining Merck and ViiV Healthcare, Gilead Sciences is now supporting and...

On November 21, 2017, the U.S. Food and Drug Administration (FDA) approved the first-ever two-drug once-daily single-pill regimen for the maintenance treatment of adults...

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

A not-for-profit biotech helps energize the future of TB vaccine R&D by Chael Needle According to the World Health Organization, tuberculosis is the most common illness...